💎💎💎
Our Neurology Pharmacy Residency program isn’t just about learning—it’s about growing your expertise in a specialty few others get to master 🦄
#NeuroPharm#PharmacyResidency@ASHPOfficial 💎💎💎
Don’t let this opportunity pass you by like a Mardi Gras Parade float 🎭✨
Visit Grady’s PGY2 Neurology Pharmacy Residency program at the ASHP Midyear Residency Showcase in New Orleans
🗓️ 12/10 8-11am CT
📍 Booth #5357
🎺🎵Let the good times roll you right up to our booth…
Join #AHAJournals in celebrating the Dr. Nanette K. Wenger Research Goes Red® Award winner. #AHA24
Saturday, Nov 16 @ 9:45-11am CT
Room: S100A
https://t.co/9D7twutdPq
🚨🚨PGY-1s interested in PGY2 Critical Care? Take 📝 and come talk with me and my residents about opportunities at a Level I Trauma and tertiary care academic center in sunny Florida 😎 🚨
#CPPPLU Highlights. This recent study from @AnnalsofPharm evaluated the efficacy of PHB in the treatment of severe AWS. Patients receiving PHB had a 2-day shorter hospital LOS than those who received BZD. #PharmICU https://t.co/HwW3SuMs3j
If you are a neurologist with a subspecialty focus on epilepsy/EEG, please take our 5-10 min survey on burnout. Our patients deserve a thriving and fulfilled workforce for this chronic and disabling condition.
https://t.co/ycaMJjueL9
A new CHEST guideline offers recommendations for red blood cell transfusion among critically ill patients overall and specifically for patients with acute coronary syndrome, #SepticShock, and more.
Read the full guideline: https://t.co/DDYPUEe77r
#ICU#MedEd
Ready to take your #Pharmacy career to the next level? 💊🌟 Join our PGY2 Neuro Pharm Residency at Grady! Train at a Comprehensive Stroke Center 🧠, respond to strokes 🚑, dive into neurology subspecialties, and fuel your passion for research 🔬. #NeuroPharmacy#PGY2
#AANAM brings together neurologists and neuroscience professionals for top-tier education, the latest scientific discoveries, and opportunities to connect with others from around the world.
Register now: https://t.co/wGLVPzrocs
#NeuroTwitter#Neurology
Our new study in @JAMA_current, in collaboration with @US_FDA@FDADeviceInfo, shows nationwide post-marketing surveillance data of IVC Filters in 270K Medicare pts(2013-2021). Insertions ⬇️but retrievals were low (∼15%),despite guideline recommendations.https://t.co/MTccy5hj8i🧵
Imagine if we could write a prescription for neurons 🧠🪄 I can think of a few populations who would benefit from a single dose and others who would need refills 🤔💊
Significant discrepancies exist between institutional productivity metric practices and their perceived value and utility among critical care pharmacists. https://t.co/bn36GqgnX8 @accpcritprn